ANIP
NASDAQ
US
ANI Pharmaceuticals, Inc. - Common Stock
$74,21
▼ $-1,75
(-2,30%)
Vol 276K
11
Skor Kualitas
ok
Pemeriksaan Mendalam
2/5
ok
Pendapatan ✓
Laba Bersih ✓
>IPO ✗
Kap. Pasar
$1.8B
P/E
43,7
ROE
8,8%
Margin
4,9%
D/E
122,64
Beta
0,50
52W
$53–$100
Konsensus Wall Street
14 analis · Apr 20265
Beli Kuat
7
Beli
2
Tahan
0
Jual
0
Jual Kuat
85,7%
Peringkat Beli
Grafik Harga
Saham Serupa
Pendapatan
Tingkat beat: 100,0%
Laporan Berikutnya
Mei 07, 2026
Estimasi EPS: $1,48
| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Mar 2026 | $1,48 | — | — |
| Des 2025 | $2,04 | $2,33 | +$0,29 |
| Sep 2025 | $1,79 | $2,04 | +$0,25 |
| Jun 2025 | $1,45 | $1,80 | +$0,35 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $190.6M | $197.1M | $211.4M | $227.8M | $247.1M |
| Laba Bersih | — | -$10.3M | $15.7M | $8.5M | $26.6M | $27.5M |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -2.3% | -2.3% | -2.3% | -2.3% | 8.8% | 8.8% |
| P/E (TTM) | — | — | — | — | 45.48 | 43.72 |
| Net Margin | 4.0% | -1.4% | -1.4% | -1.4% | 4.9% | 4.9% |
| Gross Margin | 64.7% | 61.1% | 61.1% | 61.1% | 61.1% | 61.1% |
| D/E Ratio | 134.65 | 134.65 | 134.65 | 134.65 | 122.64 | 122.64 |
| Current Ratio | 2.54 | 2.54 | 2.54 | 2.54 | 2.58 | 2.58 |
Rasio Utama
ROA (TTM)
3,1%
P/S (TTM)
2,15
P/B
2,7
EPS (TTM)
$1,94
CF/Share
$4,03
Pertumbuhan Pendapatan 3T
+41,7%
52W High
$99,50
52W Low
$52,74
$52,74
Rentang 52 Minggu
$99,50
Kesehatan Keuangan
Arus Kas Bebas
$29.0M
Utang Bersih
$331.4M
Kas
$285.6M
Total Utang
$617.0M
Per tanggal Des 31, 2025
Як ANIP виглядає на тлі конкурентів у Pharmaceuticals?
Група порівняння: Micro-cap Pharmaceuticals (All) · 171 компаній
Оцінка ANIP vs аналоги Pharmaceuticals
P/E
43,7
▲
96%
di atas
rekan
(22,4)
vs Rekan
vs Industri
Undervalued
P/S
2,2
▼
57%
di bawah
rekan
(5,0)
vs Rekan
vs Industri
Undervalued
P/B
2,7
▲
28%
di atas
rekan
(2,1)
vs Rekan
vs Industri
Lebih mahal
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(2,0%)
vs Rekan
vs Industri
Yield rendah
Прибутковість ANIP vs аналоги Pharmaceuticals
ROE
8,8%
▲
116%
di atas
rekan
(-54,3%)
vs Rekan
vs Industri
Tingkat atas
Net margin
4,9%
▲
110%
di atas
rekan
(-47,4%)
vs Rekan
vs Industri
Di bawah rata-rata
Валова маржа
61,1%
▼
10%
di bawah
rekan
(68,3%)
vs Rekan
vs Industri
Lemah
ROA
3,1%
▲
108%
di atas
rekan
(-37,4%)
vs Rekan
vs Industri
Tingkat atas
Фінансове здоровʼя ANIP vs аналоги Pharmaceuticals
D/E ratio
122,6
▲
7864%
di atas
rekan
(1,5)
vs Rekan
vs Industri
Utang tinggi
Поточна ліквідність
2,6
▼
23%
di bawah
rekan
(3,4)
vs Rekan
vs Industri
Likuiditas rendah
Beta
0,5
▼
47%
di bawah
rekan
(0,9)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів ANIP
ANIP
Median rekan
Industri
ANIP прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
ANIP vs аналоги: ключові метрики
Aktivitas Orang Dalam
NeutralPembelian
0
Penjualan
0
COOK MEREDITH
General Counsel · Mar 13
500 shs
MUTZ CHRISTOPHER
Officer · Mar 13
3162 shs
ROWLAND THOMAS ANDREW
Officer · Mar 11
4772 shs
DAVIS KRISTA
Officer · Mar 09
6572 shs
MUTZ CHRISTOPHER
Officer · Mar 09
5723 shs
CAREY STEPHEN P.
Chief Financial Officer · Mar 05
7312 shs
CAREY STEPHEN P.
Chief Financial Officer · Mar 05
3312 shs
WALSH PATRICK D
Director · Mar 03
6000 shs
GUTWERG ORI
Officer · Mar 03
2060 shs
MUTZ CHRISTOPHER
Officer · Mar 02
417 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 25,98%Blackrock Inc.
11,88%
$193.8M
Vanguard Group Inc
5,82%
$95.0M
State Street Corporation
3,24%
$53.0M
Global Alpha Capital Manage…
2,63%
$43.0M
Millennium Management Llc
2,41%
$39.3M
Per tanggal Des 31, 2025